425 related articles for article (PubMed ID: 25350125)
21. Botulinum Toxin type A injections for patients with painful hallux valgus: a double-blind, randomized controlled study.
Wu KP; Chen CK; Lin SC; Pei YC; Lin RH; Tsai WC; Fuk-Tan Tang S
Clin Neurol Neurosurg; 2015 Feb; 129 Suppl 1():S58-62. PubMed ID: 25683315
[TBL] [Abstract][Full Text] [Related]
22. Commercial preparations and handling of botulinum toxin type A and type B.
Parish JL
Clin Dermatol; 2003; 21(6):481-4. PubMed ID: 14759580
[TBL] [Abstract][Full Text] [Related]
23. Is it always necessary to apply botulinum toxin into the lower facial muscles in hemifacial spasm?: a randomized, single-blind, crossover trial.
Colakoglu BD; Cakmur R; Uzunel F
Eur Neurol; 2011; 65(5):286-90. PubMed ID: 21502764
[TBL] [Abstract][Full Text] [Related]
24. Intravesical injection of botulinum toxin A for treatment of interstitial cystitis/bladder pain syndrome: 10 years of experience at a single center in China.
Gao Y; Liao L
Int Urogynecol J; 2015 Jul; 26(7):1021-6. PubMed ID: 25690160
[TBL] [Abstract][Full Text] [Related]
25. Changes in masticatory function after injection of botulinum toxin type A to masticatory muscles.
Park HU; Kim BI; Kang SM; Kim ST; Choi JH; Ahn HJ
J Oral Rehabil; 2013 Dec; 40(12):916-22. PubMed ID: 24237358
[TBL] [Abstract][Full Text] [Related]
26. The use of Botulinum toxin-a injection for facial wrinkles: a histological and immunohistochemical evaluation.
El-Domyati M; Attia SK; El-Sawy AE; Moftah NH; Nasif GA; Medhat W; Marwan B
J Cosmet Dermatol; 2015 Jun; 14(2):140-4. PubMed ID: 25916463
[TBL] [Abstract][Full Text] [Related]
27. Botulinum toxin type A for neuropathic pain in patients with spinal cord injury.
Han ZA; Song DH; Oh HM; Chung ME
Ann Neurol; 2016 Apr; 79(4):569-78. PubMed ID: 26814620
[TBL] [Abstract][Full Text] [Related]
28. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
[TBL] [Abstract][Full Text] [Related]
29. Antibodies after botulinum toxin A injection into musculus detrusor vesicae: incidence and clinical relevance.
Hegele A; Frohme C; Varga Z; Olbert P; Kranz J; Hofmann R
Urol Int; 2011; 87(4):439-44. PubMed ID: 22004911
[TBL] [Abstract][Full Text] [Related]
30. Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia.
Xiao L; Mackey S; Hui H; Xong D; Zhang Q; Zhang D
Pain Med; 2010 Dec; 11(12):1827-33. PubMed ID: 21134121
[TBL] [Abstract][Full Text] [Related]
31. Botulinum toxin type A in chronic plantar fasciitis: clinical effects one year after injection.
Díaz-Llopis IV; Gómez-Gallego D; Mondéjar-Gómez FJ; López-García A; Climent-Barberá JM; Rodríguez-Ruiz CM
Clin Rehabil; 2013 Aug; 27(8):681-5. PubMed ID: 23411793
[TBL] [Abstract][Full Text] [Related]
32. Randomized controlled study of the efficacy of the injection of botulinum toxin type A versus corticosteroids in chronic plantar fasciitis: results at one and six months.
Díaz-Llopis IV; Rodríguez-Ruíz CM; Mulet-Perry S; Mondéjar-Gómez FJ; Climent-Barberá JM; Cholbi-Llobel F
Clin Rehabil; 2012 Jul; 26(7):594-606. PubMed ID: 22144721
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous cooling to manage botulinum toxin injection-associated pain in patients with facial palsy: A randomised controlled trial.
Pucks N; Thomas A; Hallam MJ; Venables V; Neville C; Nduka C
J Plast Reconstr Aesthet Surg; 2015 Dec; 68(12):1701-5. PubMed ID: 26385134
[TBL] [Abstract][Full Text] [Related]
34. Does vitamin B alter the efficacy of botulinum toxin?
Tatlidede S; Baslo MB; Özkaya Ö; Soydan T; Orhan EK; Yeşilada AK
Aesthetic Plast Surg; 2012 Jun; 36(3):692-7. PubMed ID: 22395300
[TBL] [Abstract][Full Text] [Related]
35. Predicting migraine responsiveness to botulinum toxin type A injections.
Kim CC; Bogart MM; Wee SA; Burstein R; Arndt KA; Dover JS
Arch Dermatol; 2010 Feb; 146(2):159-63. PubMed ID: 20157026
[TBL] [Abstract][Full Text] [Related]
36. A split-face study using botulinum toxin type B to decrease facial erythema index.
Oh YJ; Lee NY; Suh DH; Koh JS; Lee SJ; Shin MK
J Cosmet Laser Ther; 2011 Oct; 13(5):243-8. PubMed ID: 21848448
[TBL] [Abstract][Full Text] [Related]
37. Intramuscular botulinum toxin injection additional to arthrocentesis in the management of temporomandibular joint pain.
Ivask O; Leibur E; Akermann S; Tamme T; Voog-Oras Ü
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Oct; 122(4):e99-e106. PubMed ID: 27496577
[TBL] [Abstract][Full Text] [Related]
38. Vein imaging laser reduces bruising in bruise-prone botulinum toxin injected patients.
Lowe NJ; Halliday D
J Cosmet Laser Ther; 2016 Jun; 18(3):162-4. PubMed ID: 27031120
[TBL] [Abstract][Full Text] [Related]
39. Meta-analysis of botulinum toxin A detrusor injections in the treatment of neurogenic detrusor overactivity after spinal cord injury.
Mehta S; Hill D; McIntyre A; Foley N; Hsieh J; Ethans K; Teasell RW; Loh E; Welk B; Wolfe D
Arch Phys Med Rehabil; 2013 Aug; 94(8):1473-81. PubMed ID: 23632286
[TBL] [Abstract][Full Text] [Related]
40. Pain sensation during intradermal injections of three different botulinum toxin preparations in different doses and dilutions.
Kranz G; Sycha T; Voller B; Gleiss A; Schnider P; Auff E
Dermatol Surg; 2006 Jul; 32(7):886-90. PubMed ID: 16875469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
